Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nanoviricides Inc (NNVC)

Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nanoviricides Inc 1 Controls Drive Shelton CT 06484 USA

www.nanoviricides.com P: 203-937-6137

Description:

NanoViricides, Inc. is a development stage company focused on creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. It also focuses on the development of drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides, Inc. is headquartered in West Haven, Connecticut.

Key Statistics

Overview:

Market Capitalization, $K 13,664
Enterprise Value, $K 5,514
Shares Outstanding, K 11,779
Annual Sales, $ 0 K
Annual Net Income, $ -8,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,110 K
EBIT, $ -9,700 K
EBITDA, $ -8,950 K
60-Month Beta 0.67
% of Insider Shareholders 4.60%
% of Institutional Shareholders 10.30%
Float, K 11,237
% Float 95.40%
Short Volume Ratio 0.02

Growth:

1-Year Return -17.02%
3-Year Return -72.25%
5-Year Return -78.44%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 66.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 02/14/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.81
EPS Growth vs. Prev Qtr -5.88%
EPS Growth vs. Prev Year -20.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 09/24/19

NNVC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -63.96%
Return-on-Assets % -58.21%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.07
Book Value/Share 1.08
Interest Coverage -2.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar